LPAR1 and neoplasm: In addition, we checked LPAR1 expression in our in-house osteosarcoma patient-derived xenograft (PDX) samples by immunoblotting with tumor lysate and found that ~80% of the PDX tumors (15/19) were LPAR1-positive (Fig. 2F).